What Is Cardiac Amyloidosis?

June 23, 2015 Brigham and Women's Hospital

The green areas in the picture above represent a buildup of amyloid in the heart of a patient with senile amyloidosis.

Cardiac amyloidosis is a dangerous and progressive disease that is not yet well understood. As it is quite rare and produces symptoms very similar to other heart diseases, it is often misdiagnosed.

Amyloidosis refers to a group of diseases, caused by deposits of abnormal proteins (amyloid) that affect one or more organ systems in the body. Buildup of amyloid in the heart is known as cardiac amyloidosis, and whether it occurs solely in the heart or in conjunction with other organs, it is the presence of amyloidosis in the heart that determines the severity and outcome of the disease and its treatments.

To promote effective and efficient treatment and a better understanding of the disease among physicians and patients, Brigham and Women’s Hospital established a multidisciplinary program that draws upon the expertise of some of the country’s leading cardiology specialists. The program is led by noted cardiac amyloidosis expert Rodney H. Falk, MD, who, in the video below, discusses the importance of early diagnosis and the progress being made in caring for patients with the disease.

- Chris P.
Previous Article
Join the 50 Million Faces Campaign
Join the 50 Million Faces Campaign

“Nothing can prepare you for the moment when your mother looks into your...

Next Article
Diabetes 2.0 – Next-Generation Approach to Diagnosis and Treatment

Diabetes is an increasingly common disease. Overall, approximately nine...